Integrative Epigenetic Analysis Reveals Therapeutic Targets to the DNA Methyltransferase Inhibitor Guadecitabine (SGI‐110) in Hepatocellular Carcinoma-Reference-Cited by-同舟云学术

Integrative Epigenetic Analysis Reveals Therapeutic Targets to the DNA Methyltransferase Inhibitor Guadecitabine (SGI‐110) in Hepatocellular Carcinoma

Published:2018-10 Issue:4 Volume:68 Page:1412-1428
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Liu Minmin¹²,Zhang Lian¹³,Li Hongtao¹,Hinoue Toshinori²,Zhou Wanding²,Ohtani Hitoshi¹²,El‐Khoueiry Anthony⁴,Daniels John⁴,O'Connell Casey⁴,Dorff Tanya B.⁴^ORCID,Lu Qianjin³,Weisenberger Daniel J.⁵,Liang Gangning¹

Affiliation:

1. Department of Urology, Keck School of MedicineUniversity of Southern California Los Angeles CA

2. Van Andel Research Institute Grand Rapids MI

3. Department of Dermatology, Hunan Key Laboratory of Medical Epigenomics, Second Xiangya HospitalCentral South University Changsha Hunan China

4. Department of Medicine, Keck School of MedicineUniversity of Southern California Los Angeles CA

5. Department of Biochemistry & Molecular Medicine, Keck School of MedicineUniversity of Southern California Los Angeles CA

Funder

National Institutes of Health

National Cancer Institute

Publisher

Wiley

Subject